Biotech entity
Every one of those 1 sits in a single category, funding. Of the tracked stories, 1 of 1 also mention Congress, the most common co-covered peer. We currently track 1 Biotech story that mention Harvard University, all published on September 20, 2026.
Last mentioned: 13h ago
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, funding. Of the tracked stories, 1 of 1 also mention Congress, the most common co-covered peer. We currently track 1 Biotech story that mention Harvard University, all published on September 20, 2026. Each carries 4 original sources on average.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 1 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Harvard University. Shared-story counts are live from our verified record — not editorial picks.
Biotech and pharma startups often leverage NIH grants, including SBIR/STTR awards, to validate early science and attract venture funding. A White House board with unanimous approval power over $48 billion could change which research gets funded, reshaping pipelines and investor risk.
Source: wcyb.com · nebraska.tv
Harvard University is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
